Central nervous system metastases in advanced breast cancer patients treated with trastuzumab
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 2
Abstract
Amplification or overexpression of HER2 receptor is present in 20-30% of invasive breast cancers and in 60% of intraductal cancers. Patients with HER2 gene aberrations have more aggressive disease, frequent disease recurrence and a shorter survival. Trastuzumab (herceptin) is a monoclonal antibody selectively directed against the HER2 epidermal growth factor receptor. Adding herceptin to therapy of metastatic breast cancer patients with overexpression and/or amplification of HER2 has increased complete and partial response rates, as well as prolonged time to progression and overall survival. A common failure site during trastuzumab therapy is brain. Brain dissemination is probably related to the lack of CNS penetration of trastuzumab, a consequence of its high molecular weight (145 kDa). Another hypothesis includes improved systemic disease control outside the brain, leading to prolonged survival without brain protection (a ”sanctuary site”). It was also postulated that HER2 overexpression and/or amplification might predispose to brain metastases. The aim of this article is to discuss the pathomechanism of this phenomenon and its clinical implications.
Authors and Affiliations
Renata Duchnowska, Cezary Szczylik
Keywords
Related Articles
- EP ID EP139082
- DOI -
- Views 55
- Downloads 0
Cancer-related anaemia
Cancer-related anaemia occurs during the underlying malignancy in 40-75 percent of the patients. It has the influence on the quality of life, which can be significantly reduced and on the results of the planned and und...
Bone marrow suppression induced by systemic radionuclides (153Sm) in metastatic breast cancer patients with bone metastases, its impact on subsequent chemotherapy
Introduction: Bone metastases are present in approximately 75 percent of breast cancer patients, therefore bones are the most frequent localization of metastases and the only site of metastatic spread in many patients....
Przerzuty do ośrodkowego układu nerwowego u chorych na rozsianego raka piersi leczonych trastuzumabem
Amplifikacja genu HER2 i/lub nadekspresja receptora HER2 występuje w 20–30 proc. inwazyjnych raków piersi i w 60 proc. raków śródprzewodowych. U chorych na inwazyjnego raka piersi zaburzenia genu HER2 związane są z bar...
Leczenie operacyjne przerzutów do wątroby w przebiegu raka jelita grubego
Estimation of quality of life in patients after surgery for lung cancer
Introduction: Lung cancer is the biggest challenge to modern medicine. Lung cancer incidence and mortality remain at a constant very high level, in particular among men. About 20000 persons develop lung cancer and approx...